Physician profile
Devon Buck
NPI 1003264292
$1,107.51
in general payments reported to CMS, 2019-2025
10 companies · $25.90 in 2025
The $25.90 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $599 · 2022: $74.98 · 2023: $389 · 2024: $18.97 · 2025: $25.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $433.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $418.48 | 2021-2025 | Resonate El Icd Vr, Emblem Mri S-Icd, Accolade Sr |
| Abbott Laboratories | $218.49 | 2021-2024 | Pressurewire |
| Cvrx, INC. | $157.03 | 2023 | Barostim Neo System |
| Astrazeneca Pharmaceuticals Lp | $109.27 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $66.03 | 2021-2023 | Lifevest |
| Inari Medical, INC. | $59.11 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lilly USA, LLC | $38.60 | 2021 | |
| Ibsa Pharma INC. | $14.65 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.09 | 2021 | |
| Amgen INC. | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Buck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.